Systemic lupus erythematosus
|
1
|
3
|
2
|
|
1
|
1
|
Hepatitis C |
|
|
|
|
10 |
2 |
Complement and coagulation cascades |
2 |
|
|
3 |
3 |
3 |
RIG-I-like receptor signaling pathway |
|
1 |
3 |
|
9 |
4 |
Cytosolic DNA-sensing pathway |
|
2 |
1 |
|
4 |
5 |
Osteoclast differentiation |
|
|
|
|
7 |
6 |
Chemokine signaling pathway |
|
|
6 |
|
|
7 |
Lysosome |
|
|
|
|
|
8 |
Antigen processing and presentation |
|
|
9 |
|
|
9 |
NOD-like receptor signaling pathway |
|
4 |
4 |
|
|
10 |
Toll-like receptor signaling pathway |
|
6 |
8 |
|
5 |
11 |
Staphylococcus aureus infection
|
|
|
|
|
2
|
|
Long term potentiation |
|
|
10 |
|
|
|
Leishmania infection
|
|
5
|
11
|
|
|
|
Ribosome |
|
|
5 |
|
|
|
Malaria
|
|
|
|
|
6 |
|
Allograft rejection |
|
|
7 |
|
|
|
Prion diseases
|
|
|
12
|
|
8
|
|
Measles |
|
|
|
1 |
|
|
Influenza A |
|
|
|
2 |
|
|
Herpes simplex infection |
|
|
|
4 |
|
|
Pertussis
|
|
|
|
5
|
|
|